Lexicon Pharmaceuticals | LXRX - Ebit





Ebit Zmiana Data
Abbott USD 1.85B 684M 2026-03
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Illumina USD 239M 17M 2026-03
Insmed USD -249.71M 11.64M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 6.62B 1.51B 2026-03
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
MannKind USD -69.24M 28.19M 2025-12
Merck USD -1.88B 8.12B 2026-03
Moderna USD -1.39B 531M 2026-03
Novartis USD 4.18B 118M 2026-03
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12